SEE Q4 2025 Earnings Earnings Beat Driven by Operational Discipline Revenue Details Unavailable HRTG Q1 2026 Earnings EPS Misses Estimates Stock Declines MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline BIPC Q1 2026 Earnings Significant EPS Miss Raises Concerns EWTX Q1 2026 Earnings EPS Beats Estimates as Clinical Pipeline Progresses ASTC Q1 2024 Earnings Continued Losses Amid Strategic Repositioning